Bulletin
Investor Alert

Gilead Sciences Inc.

NAS: GILD

GO
/marketstate/country/us

After Hours

/zigman2/quotes/210293917/composite

$

68.60

Change

+0.07 +0.10%

Volume

Volume 255,940

May 14, 2021, 7:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/210293917/composite

Previous close

$ 68.91

$ 68.53

Change

-0.38 -0.55%

Day low

Day high

$68.39

$69.18

Open
Open: 68.91

52 week low

52 week high

$56.56

$79.31

Open

Market cap

$85.95B

Average volume

7.66M

P/E ratio

302.03

Rev. per Employee

$1.81M

EPS

0.23

Dividend

0.71

Div yield

4.14%

Ex dividend date

6/14/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gild

MarketWatch News on GILD

  1. Regeneron Earnings Lift Stock. Here's Why.

    7:34 a.m. May 6, 2021

    - Josh Nathan-Kazis

  2. Pfizer Expects $26B in Covid-19 Vaccine Sales This Year

    10:24 a.m. May 4, 2021

    - Josh Nathan-Kazis

  3. Moderna to Sell Up to 500 Million Covid Vaccine Doses to COVAX

    9:58 a.m. May 3, 2021

    - Josh Nathan-Kazis

  4. What Ails Gilead's Sales

    6:59 p.m. April 29, 2021

    - Bill Alpert

  5. Gilead stock falls as COVID-19 drug sales dwindle

    4:27 p.m. April 29, 2021

    - Jeremy C. Owens

  6. Gilead stock falls as COVID-19 drug sales dwindle

    4:26 p.m. April 29, 2021

    - Jeremy C. Owens

  7. Merck and Gilead Sciences Sign Deals to Aid India's Covid-19 Fight

    11:34 a.m. April 27, 2021

    - Josh Nathan-Kazis

  8. Gilead to donate 450,000 doses of COVID-19 drug to India

    7:14 a.m. April 27, 2021

    - Jaimy Lee

  9. Buy Moderna Stock. It’s More Than a One-Hit Wonder.

    6:55 a.m. April 26, 2021

    - Josh Nathan-Kazis

  10. Buy Moderna Stock. It’s More Than a One-Hit Wonder.

    1:03 p.m. April 23, 2021

    - Josh Nathan-Kazis

  11. FDA Grants Full Approval to Gilead Breast Cancer Drug

    8:14 a.m. April 8, 2021

    - Josh Nathan-Kazis

  12. Futures Inch Up on Employment News

    9:22 a.m. April 2, 2021

    - Jacob Sonenshine

  13. Biotech Is Sliding, so Stock Picking Is Key, Analyst Writes

    9:39 a.m. March 25, 2021

    - Josh Nathan-Kazis

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/gild

Other News on GILD

  1. Don’t Apply Old School Valuation Metrics to New School Ethereum

    2:54 p.m. May 12, 2021

    - InvestorPlace.com

  2. 10-Q: KRONOS BIO, INC.

    4:12 p.m. May 11, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  3. Highlighting 5 Potential Dividend Yield Plays To Consider

    3:12 p.m. May 10, 2021

    - Seeking Alpha

  4. 3 Global Value Stocks to Buy Now

    6:35 a.m. May 7, 2021

    - Motley Fool

  5. Biden’s Vaccine Patent Move: Watch Out for Side Effects

    9:09 a.m. May 6, 2021

    - Charley Grant

  6. Why Humanigen Stock Vaulted Higher Today

    2:59 p.m. May 5, 2021

    - Motley Fool

  7. 10-Q: JOUNCE THERAPEUTICS, INC.

    2:52 p.m. May 4, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  8. Maxim Group Sticks to Its Buy Rating for Gilead Sciences (GILD)

    10:24 a.m. May 4, 2021

    - SmarterAnalyst

  9. COCP Stock: Cocrystal Pharma Gains 40% on Big Covid-19 News

    8:59 a.m. May 4, 2021

    - InvestorPlace.com

  10. Gilead Sciences: To Buy, Or Not To Buy - That Is The Question

    11:48 a.m. May 3, 2021

    - Seeking Alpha

  11. J.P. Morgan Keeps a Hold Rating on Gilead Sciences (GILD)

    11:25 a.m. May 3, 2021

    - SmarterAnalyst

  12. Loading more headlines...
/news/pressrelease/company/us/gild

Press Releases on GILD

  1. Gilead Sciences to Present at Upcoming Investor Conferences

    4:05 p.m. May 14, 2021

    - BusinessWire - BZX

  2. Nanopharmaceuticals Market is Growing at a CAGR of 13.0% by 2027

    3:46 a.m. May 13, 2021

    - Market Stats News

  3. Former Penny Stocks To Watch Making Their Mark In 2021

    10:58 a.m. May 12, 2021

    - Penny Stocks

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.